BKYI

BIO KEY INTERNATIONAL INC
—

Company Information

Company Name
BIO KEY INTERNATIONAL INC
CIK
CIK0001019034
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
BKYI: Nasdaq
Fiscal Year End
December 31
Owner Organization
06 Technology
SIC
7372
SIC Description
Services-Prepackaged Software
Ticker
BKYI

SEC filing data through

Insider Sentiment

Last purchase
2025-09-16
Last sale
—
Shares purchased (TTM)
20,617
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
407,449
Shares outstanding
1,035,147
Ownership
39.36%
-64.93% Y/Y

Earnings Market Reaction

Filing date
2026-08-13
Price on filing date
—
1-month reaction
-25.46%
3-month reaction
…
Drift continued3/7 (43%)
Faded / reversed4/7 (57%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Cash And Cash Equivalents At Carrying Value123223021110
Accounts Receivable Net Current221111121113
Other Assets Current--0000000000
Inventory Net000000000004
Prepaid Expense And Other Assets Current000000000000
Assets Current445445253238
Property Plant And Equipment Net000000000000
Assets
Assets7881011119654510
Capitalized Contract Cost Net Noncurrent00000000000-
Contract With Customer Asset Net Noncurrent----------00
Deposits Assets Noncurrent00000000--00
Deferred Offering Costs-----------0
Operating Lease Right Of Use Asset000000000000
Long Term Investments---5555---0-
Investments333---5-----
Intangible Assets Net Excluding Goodwill111111111112
Assets Noncurrent444667722222
Long Term Debt Current---------000
Accounts Payable Current011111122112
Accrued Liabilities Current-11111111111
Liabilities
Liabilities333444566436
Accrued Income Taxes Current-----------0
Short Term Borrowings----------02
Notes Payable Current---0--------
Contract With Customer Liability Current111111111101
Operating Lease Liability Current000000000000
Liabilities Current333343566336
Contract With Customer Liability Noncurrent000000000000
Long Term Debt Noncurrent----00000000
Long Term Notes Payable---1--------
Deferred Income Tax Liabilities Net000---000000
Long Term Loans Payable--00--0-----
Operating Lease Liability Noncurrent00000000--00
Liabilities Noncurrent000100000000
Common Stock Value000000000000
Stockholders Equity
Additional Paid In Capital142142141138138138133128126126126122
Stockholders Equity45567840-311-0
Accumulated Other Comprehensive Income Loss Net Of Tax-00000000-0-00-0
Retained Earnings Accumulated Deficit-137-137-136-132-131-130-129-128-127-126-125-119
Liabilities And Stockholders Equity7881011119654510
Common Stock Shares Authorized170170170170170170170170170170170170
Common Stock Shares Issued111111000000
Shares Outstanding111111000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

BIO KEY INTERNATIONAL INC (BKYI) — SEC Financial Statements & Analysis

BIO KEY INTERNATIONAL INC (BKYI) is a services-prepackaged software company, incorporated in DE. BIO KEY INTERNATIONAL INC trades on Nasdaq as: BKYI. BIO KEY INTERNATIONAL INC (BKYI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, BIO KEY INTERNATIONAL INC carries a market cap of $4.68M, a P/E ratio of -0.77x, a P/B ratio of 1.08x, a P/S ratio of 0.70x, an enterprise value of $3.30M, and an EV/EBITDA multiple of -0.58x. On profitability, it posts a gross margin of 81.32%, an operating margin of -86.43%, a net margin of -90.10%, a Return on Equity (ROE) of -107.91%, a Return on Assets (ROA) of -67.07%, and a Return on Invested Capital (ROIC) of -147.97%. Per share, it reports EPS of $-5.82, free cash flow per share of $-4.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -3.07% year-over-year, net income growth of 49.87% year-over-year, and EPS growth of -15.88% year-over-year. On the balance sheet, it maintains a current ratio of 1.26x, a quick ratio of 1.03x, working capital of $793.45K, a debt-to-equity ratio of 0.73x, a debt ratio of 0.42, an interest coverage ratio of -71.25x, free cash flow of $-4.16M (TTM), and net debt of $-1.38M. Figures sourced from SEC EDGAR.

Market Cap
$4.68M
P/E TTM
-0.77x
EPS TTM
$-5.82
P/B TTM
1.08x
ROE TTM
-107.91%
ROA TTM
-67.07%
Debt To Equity
0.73x
Free Cash Flow TTM
$-4.16M
Net Revenue TTM Growth 1Y
-3.07%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BIO KEY INTERNATIONAL INC in?

BIO KEY INTERNATIONAL INC (BKYI) operates in the Services-Prepackaged Software industry.

What exchange does BKYI trade on?

BIO KEY INTERNATIONAL INC (BKYI) trades on the Nasdaq.

Where is BIO KEY INTERNATIONAL INC incorporated?

BIO KEY INTERNATIONAL INC is incorporated in DE.

When was BIO KEY INTERNATIONAL INC (BKYI)'s most recent SEC filing?

BIO KEY INTERNATIONAL INC (BKYI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.

What is BKYI's market cap?

BIO KEY INTERNATIONAL INC (BKYI) has a market capitalization of $4.68M as of 2026-06-30.

What is BKYI's EPS (earnings per share)?

BIO KEY INTERNATIONAL INC (BKYI)'s trailing twelve month EPS is $-5.82 as of 2026-06-30.

What is BKYI's ROE (return on equity)?

BIO KEY INTERNATIONAL INC (BKYI)'s trailing twelve month Return on Equity (ROE) is -107.91% as of 2026-06-30.

What is BKYI's ROA (return on assets)?

BIO KEY INTERNATIONAL INC (BKYI)'s trailing twelve month Return on Assets (ROA) is -67.07% as of 2026-06-30.

What is BKYI's ROIC (return on invested capital)?

BIO KEY INTERNATIONAL INC (BKYI)'s trailing twelve month Return on Invested Capital (ROIC) is -147.97% as of 2026-06-30.

What is BKYI's EV/EBITDA?

BIO KEY INTERNATIONAL INC (BKYI)'s trailing twelve month EV/EBITDA is -0.58x as of 2026-06-30.

Wall Street's data.
Main Street's price.